Gold Prices in a Fe...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$2.11 -0.02 | -0.94%
02/08/12 - 04:00 PM ET
66.27K / 322.50K
Vol / Avg. Vol:2.12 / 2.13
Open / Prev. Close:2.07 - 2.12
Today's Range:0.77 - 4.05
52 Wk Range:155.87%
Performance YTD:TheStreet Rating:
Portfolios with BDSI
- Portfolio NameUser Type
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
- UserSmall Cap Bargains to follo...
- UserPROS
- UserCloud66 - IRA
- UserRAPTOR LAST 4
- Userwovlerbuy Portfolio 1
- ContributorTop 10 Insider Sales: June 29
- Usertsantamaria Portfolio 1
- Userua
Latest BDSI Headlines from TheStreet
- 10 Stocks Under $5 Outperforming in 2012 01.31.12 | 05:01 am
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 04.01.11 | 06:04 pm
- IPO Watch: 2011 02.16.11 | 01:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- Stock Offerings: MGIC Investment 04.20.10 | 11:04 am
- Zanett, Novell: Early Volume Plays 03.22.10 | 09:03 am
- Hovnanian, BioDelivery: Early Volume Plays 12.17.09 | 07:12 am
Press Releases for BDSI
- BioDelivery Sciences Announces Worldwide License And Development Agreement With Endo Pharmaceuticals For BEMA Buprenorphine - PR Newswire 01.06.12 | 06:01 am
- Endo Pharmaceuticals And BioDelivery Sciences International Sign Licensing Agreement For BEMA Buprenorphine - PR Newswire 01.06.12 | 06:01 am
- ONSOLIS To Benefit From Approval Of Class-Wide REMS For All Transmucosal Fentanyl Products - PR Newswire 12.29.11 | 02:12 pm
- BioDelivery Sciences Announces Confirmation Of Final Formulation Of BEMA Buprenorphine/Naloxone Based On Positive BNX-102 Study - PR Newswire 12.20.11 | 04:12 pm
- US Patent Office Rejects All 191 Claims In Key MonoSol Patent Asserted Against BioDelivery Sciences - PR Newswire 11.28.11 | 07:11 am
- BioDelivery Sciences To Present At The 23rd Annual Piper Jaffray Healthcare Conference - PR Newswire 11.21.11 | 07:11 am
- BioDelivery Sciences To Host Business Update Webcast And Conference Call On Tuesday, November 15, 2011 At 8:30 AM Eastern Time - PR Newswire 11.14.11 | 07:11 am
- BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study Of BEMA Buprenorphine/Naloxone Compared To Suboxone - PR Newswire 11.10.11 | 07:11 am
- BEMA Fentanyl Submitted For Marketing Authorization In Taiwan - PR Newswire 11.07.11 | 08:11 am
- Samuel J. Sears, Jr. Appointed To BioDelivery Sciences Board Of Directors - PR Newswire 10.25.11 | 07:10 am
Partner Headlines for BDSI
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- This Week's Healthcare Stock Watch - Seeking Alpha 09.20.11 | 09:09 am
- Options Brief: BioDelivery Sciences International (BDSI) - Benzinga 12.28.10 | 09:12 am
- BioDelivery Sciences: Signs of Life - Seeking Alpha 09.10.10 | 03:09 pm
- BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug - Fox Business 09.02.10 | 05:09 pm
- Seven Trades on FDA, Clinical Trial Binary Events - Seeking Alpha 05.31.10 | 12:05 pm
- BioDelivery Sciences International: Why I Believe Patience Will Reward Investors - Seeking Alpha 05.12.10 | 01:05 pm
- Cephalon Beats; Updates Guidance - Analyst Blog - Zacks 05.05.10 | 10:05 am
- Biotech CROs Take Center Stage in Recent Deals - Seeking Alpha 05.02.10 | 05:05 am
